Stabilization of the GluCl ligand-gated ion channel in the presence and absence of ivermectin.
Improving our understanding of the mechanisms and effects of anesthetics is a critically important part of neuroscience. The currently dominant theory is that anesthetics and similar molecules act by binding to Cys-loop receptors in the postsynaptic terminal of nerve cells and potentiate or inhibit their function. Although structures for some of the most important mammalian channels have still not been determined, a number of important results have been derived from work on homologous cationic channels in bacteria. However, partly due to the lack of a nervous system in bacteria, there are a number of questions about how these results relate to higher organisms. The recent determination of a structure of the eukaryotic chloride channel, GluCl, is an important step toward accurate modeling of mammalian channels, because it is more similar in function to human Cys-loop receptors such as GABAAR or GlyR. One potential issue with using GluCl to model other receptors is the presence of the large ligand ivermectin (IVM) positioned between all five subunits. Here, we have performed a series of microsecond molecular simulations to study how the dynamics and structure of GluCl change in the presence versus absence of IVM. When the ligand is removed, subunits move at least 2 Å closer to each other compared to simulations with IVM bound. In addition, the pore radius shrinks to 1.2 Å, all of which appears to support a model where IVM binding between subunits stabilizes an open state, and that the relaxed nonIVM conformations might be suitable for modeling other channels. Interestingly, the presence of IVM also has an effect on the structure of the important loop C located at the neurotransmitter-binding pocket, which might help shed light on its partial agonist behavior.
Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden.
Ozge
O
Yoluk
Torben
T
Brömstrup
Edward J
EJ
Bertaccini
James R
JR
Trudell
Erik
E
Lindahl
D000595:Amino Acid Sequence; D000818:Animals; D018118:Chloride Channels / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism; D015640:Ion Channel Gating / Q000187:drug effects; D007559:Ivermectin / Q000737:chemistry / Q000494:pharmacology*; D008024:Ligands; D008253:Macaca mulatta; D062105:Molecular Docking Simulation; D056004:Molecular Dynamics Simulation; D008969:Molecular Sequence Data; D017434:Protein Structure, Tertiary; D021122:Protein Subunits / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism
D018118:Chloride Channels; D008024:Ligands; D021122:Protein Subunits; C109777:glutamate-gated chloride channels; D007559:Ivermectin